Addressing SARS-CoV-2 viroporins with antiarrhythmic drugs

Europace. 2024 Oct 3;26(10):euae254. doi: 10.1093/europace/euae254.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Arrhythmia Agents* / therapeutic use
  • Antiviral Agents / therapeutic use
  • Arrhythmias, Cardiac / drug therapy
  • Arrhythmias, Cardiac / physiopathology
  • COVID-19 Drug Treatment
  • COVID-19*
  • Humans
  • SARS-CoV-2*

Substances

  • Anti-Arrhythmia Agents
  • Antiviral Agents